Loading company…
Riskpilot
← Back to search
Sign in
Get full access
C Molund LifeScience AB
AB
Active
Org 5593771669
Stabby Allé 8 A
Business and other management consultancy activities · NACE 7020
Est. 2022
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 96K
+75% vs 2023
EBITDA margin
85.4%
+128% vs 2023
Equity ratio
64.1%
Financial strength
Net profit 2024
SEK 12K
-57% vs 2023
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
SEK 96K
+75%
EBITDA
SEK 82K
+128%
Net profit
SEK 12K
-57%
Total assets
SEK 103K
-28%
Equity
SEK 66K
+25%
Employees
0
—
Company information
Legal name
C Molund LifeScience AB
Org number
5593771669
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
25 april 2022
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska äga aktier, andelar och optioner i andra företag samt erbjuda konsultuppdrag inom styrelse- och managementarbete inom LifeScience.
Contact
Address
Stabby Allé 8 A
Email
catrin.molund@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Business and other management consultancy activities
Companies in Uppsala
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
Income statement
SEK thousands
Item
2022
2023
2024
Revenue
0
55
96
Staff expenses
—
—
—
EBITDA
—
36
82
Depreciation & amort.
—
−0
−0
EBIT
0
36
82
Net financials
—
—
−53
Profit before tax
0
35
29
Tax
—
−7
−17
Net profit
0
28
12
Balance sheet
SEK thousands
Item
2022
2023
2024
Total assets
100
143
103
Equity
25
53
66
Long-term debt
75
75
0
Short-term debt
0
14
37
Total debt
75
89
37
Financial ratios
5-year trend
EBITDA margin
85.4%
This company
15.8%
Market median
+441% vs market
2022
2024
Equity ratio
64.1%
This company
38.2%
Market median
+68% vs market
2022
2024
Return on equity
18.2%
This company
18.4%
Market median
+1% vs market
2022
2024
Net profit margin
12.5%
This company
8.1%
Market median
+54% vs market
2022
2024
Asset turnover
0.93×
This company
1.12×
Market median
+17% vs market
2022
2024
Debt / equity
0.56×
This company
0.62×
Market median
+10% vs market
2022
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-04-25 – 2022-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
PO
Per Olof Molund
Deputy Board Member
2022
CE
Charlotte Eva Catrin Molund
Board of Directors
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of C Molund LifeScience AB also hold positions in
0
other companies.
Person
Role here
Other companies
Per Olof Molund
Deputy Board Member
0 companies
Charlotte Eva Catrin Molund
Board of Directors
0 companies